| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/02/2002 | WO2002034243A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2002034242A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2002034213A2 Oral composition providing enhanced tooth stain removal |
| 05/02/2002 | WO2002034205A2 Using heat shock proteins to increase immune response |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2002034201A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | WO2002034119A2 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002018446A3 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2002002121A3 Method for treatment and prevention of mastitis |
| 05/02/2002 | WO2001098473A3 Method for isolating and purifying a protein and resulting protein |
| 05/02/2002 | WO2001096527A3 Peptides with physiological activity |
| 05/02/2002 | WO2001096524A3 A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 05/02/2002 | WO2001093837A3 Protein powder for pulmonary delivery |
| 05/02/2002 | WO2001092301A3 Placc, a novel human c-c chemokine isolated from placenta |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001091774A3 Method of treating chronic ulcers |
| 05/02/2002 | WO2001091773A3 Method of stimulating hair growth |
| 05/02/2002 | WO2001090745A3 Determination of naaladase inhibitors |
| 05/02/2002 | WO2001090332A3 Dna repair polypeptides and methods of use |
| 05/02/2002 | WO2001089450A3 Treating musculoskeletal disorders using lp85 and analogs thereof |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001082945B1 The use of bacterial phage associated lysing enzymes for treating various illnesses |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001073048A3 Pi3k - regulatory subunit homology |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001070951A3 Agent for the diagnosis and therapy of viral diseases |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001066759A3 26886, a novel carnitine acyltransferase family member and uses therefor |
| 05/02/2002 | WO2001064873A3 Human gtpase activator proteins |
| 05/02/2002 | WO2001064741A3 Methods for selectively modulating survivin apoptosis pathways |
| 05/02/2002 | WO2001062931A3 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001062794A3 18607, a human calcium channel |
| 05/02/2002 | WO2001062289A3 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 05/02/2002 | WO2001062269A3 Use of neurotoxins for treating parathyroid disorders |
| 05/02/2002 | WO2001062266A3 Use of dpp-iv inhibitors for the treatment of diabetes |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001060317A3 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 05/02/2002 | WO2001060162A3 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 05/02/2002 | WO2001057189A3 Fas pathway genes |
| 05/02/2002 | WO2001056544A3 Shell-and-core dosage form approaching zero-order drug release |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001055332A3 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 05/02/2002 | WO2001055314A3 Digestive system related nucleic acids, proteins and antibodies |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001054686A3 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 05/02/2002 | WO2001053455A3 Novel nucleic acids and polypeptides |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001044287A3 Novel polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001040301A3 A gene, disrupted in schizophrenia |
| 05/02/2002 | WO2001036979A3 Placental human neurokinin b precursor |
| 05/02/2002 | WO2001036475A3 Biglycan and related therapeutics and methods of use |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001028525A3 Method of producing sub-micron particles of biologically active agents |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2001023538A3 Molecules for disease detection and treatment |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001005803A9 NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078960A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | US20020052513 Oxamide IMPDH inhibitors |
| 05/02/2002 | US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy |
| 05/02/2002 | US20020052489 Nuclear bindng protein for use as tools in controlling gene transcription |
| 05/02/2002 | US20020052488 Replacement polypeptide for use in the treatment of nervous system disorders |
| 05/02/2002 | US20020052487 Transcripts of the MHC class I HLA-G gene and their applications |
| 05/02/2002 | US20020052483 Intestinal trefoil proteins |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052480 Recombinant antibody proteins that specifically bind fibroblast activation protein alpha (FAP alpha ) and comprise framework modifications; anticarcinogenic, -tumor agents; diagnostic imaging |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052476 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052474 Protein for use in the diagnosis and treatment of cell death defects |
| 05/02/2002 | US20020052473 Polypeptide for use as diagnostic tool and in the treatment of sepsis, arthritis, graft versus host disease, and stroke; antiischemic agents |
| 05/02/2002 | US20020052472 ama |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052469 Amino acid sequences for use in detection and treatment of viral infection |
| 05/02/2002 | US20020052443 Non-antigenic branched polymer conjugates |
| 05/02/2002 | US20020052422 Oral drug delivery compositions and methods |
| 05/02/2002 | US20020052415 Treating chronic uremic patients undergoing periodical dialysis |
| 05/02/2002 | US20020052407 Modulating expression, production, or formation of amyloid precursor protein by administering a nonsteroidal antiinflammatory agent that is a cyclooxygenase inhibitor |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/02/2002 | US20020052372 Using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins |
| 05/02/2002 | US20020052359 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/02/2002 | US20020052354 Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction |
| 05/02/2002 | US20020052351 Novel medical use for tachykinin antagonists |